Mounjaro vs Wegovy
Both medicines support weight management alongside healthy lifestyle changes. They work in related but slightly different ways, and suitability depends on the individual.
What is Mounjaro?
Mounjaro contains tirzepatide. It mimics two naturally occurring hormones involved in appetite regulation: GLP-1 and GIP.
- May reduce appetite and food cravings
- Can increase feelings of fullness
- Slows stomach emptying
What is Wegovy?
Wegovy contains semaglutide. It mimics GLP-1, helping regulate hunger and food intake. It is used for weight management alongside dietary and lifestyle changes.
Key differences
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Active ingredient | Tirzepatide | Semaglutide |
| Hormones targeted | GLP-1 and GIP | GLP-1 |
| Administration | Weekly injection | Weekly injection |
| Dose escalation | Yes | Yes |
| Appetite reduction | Significant | Significant |
| Weight-loss potential | Higher averages in some clinical trials | Significant clinical results |
Which produces greater weight loss?
Clinical studies suggest tirzepatide may produce greater average weight loss than semaglutide in some populations. Results still vary with starting weight, diet, physical activity, adherence and underlying health conditions.
Which should you choose?
There is no one-size-fits-all answer. Your clinician considers BMI, medical history, current medicines and previous weight-loss attempts. Both medicines can cause nausea, vomiting, diarrhoea, constipation, indigestion and reduced appetite, especially after starting or increasing a dose.